Bookmark

Add to MyYahoo RSS

Rosetta Genomics News

News on Rosetta Genomics (Ticker: ROSG) continually updated from thousands of sources around the net.

Friday Apr 4 | Sys-Con Media

Rosetta Genomics to Receive U.S. Patent for Cancer Origin Assay

PRINCETON, NJ and REHOVOT, ISRAEL -- -- 04/04/14 -- Rosetta Genomics Ltd. , a leading developer and provider of microRNA-based molecular diagnostics and therapeutics, today announced that the Company received a Notice of Allowance from the United States Patent and Trademark Office for a patent covering the method of use of a core element of Rosetta ... (more)

Comment?

Related Topix: Biotech, Princeton, NJ, USPTO, Inventions, Science / Technology, Health, Mesothelioma, Lung Cancer

Wed Apr 02, 2014

Sys-Con Media

Rosetta Genomics and Marina Biotech Establish Strategic Alliance to...

The Alliance is exclusive as it relates to neuromuscular diseases and dystrophies, with both Companies free to develop and collaborate outside this field both during and after the terms of the Alliance.

Comment?

Related Topix: Nastech Pharmaceutical Company, Biotech, Medicine, MDRNA, Healthcare Industry

Mon Mar 31, 2014

MacReport Media RSS Feed

Rosetta Genomics Reports 2013 Financial Results

Recorded gross billings for 2013 of $1.1 million, which more than doubled from $490,000 in 2012, with commercial initiatives continuing to gain significant traction as evidenced by gross billings of nearly $600,000 in the first quarter of 2014; Executed credentialing agreements for the Rosetta Cancer Origin Test with four U.S. national healthcare ... (more)

Comment?

Related Topix: Biotech, Health, Liver Cancer, Lung Cancer

Tue Mar 25, 2014

Sys-Con Media

Rosetta Genomics to Host Business Update Conference Call on April 1, 2014

The Form 20-F will include audited annual consolidated financial statements, as well as additional information regarding the Company.

Comment?

Related Topix: Biotech, Securities and Exchange Commission, Corporate / Securities Law, Law, US Securities and Exchange Commission, Financial Services, Health, Mesothelioma, Lung Cancer

Mon Mar 24, 2014

MacReport Media RSS Feed

Rosetta Genomics Enters Collaboration With Clalit Health Services'...

Under the terms of the agreement, Rosetta will partially fund the research and receive an exclusive worldwide license to the technology, including the right to sublicense the technology.

Comment?

Related Topix: Biotech, Kidney Cancer

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••
•••